Board Meeting30 May 2026, 09:31 am
Fischer Medical Ventures Recommends ₹0.05 Dividend
AI Summary
Fischer Medical Ventures Ltd's board approved audited financial results for the quarter and year ended March 31, 2026, with an unmodified audit opinion from Bilimoria Mehta & Co. They recommended a final dividend of ₹0.05 per equity share, pending AGM approval. S. Ramanand Aiyer & Co. were appointed as internal auditors for FY 2026-27. The Board Meeting commenced at 9.00 PM (IST) and concluded at 11.00 PM (IST).
Key Highlights
- Audited financial results (standalone and consolidated) for FY26 approved with unmodified opinion.
- Final dividend of ₹0.05 per equity share recommended for FY26, subject to AGM approval.
- S. Ramanand Aiyer & Co. appointed as internal auditors for FY 2026-27.
- Standalone revenue from operations for FY26 is ₹1,739.18 Lakhs.
- Consolidated revenue from operations for FY26 is ₹30,857.56 Lakhs.
Price Impact
More from FISCHER